Bumper Offer - Urjas oil Just @ Rs. 1
Levotas is a prescription medicine that is available as a Tablet. Primarily, it is used for the treatment of Urinary Tract Infection, Prostatitis, Pneumonia. Levotas also has some secondary and off-label uses. These are listed below.
The optimal dosage of Levotas is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
While these are the most often observed Levotas side effects, there are can be others also. These have been listed below. These side effects of Levotas are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Levotas's effect during pregnancy is Moderate and Severe while nursing. Further, the section on Levotas related warnings talks about Levotas's effects on the liver, heart and kidney.
Levotas can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Levotas in conditions like Coronary Artery Disease (CAD), Heart Disease, Myasthenia Gravis (MG). Other contraindications of Levotas have been discussed in the sections ahead.
Additionally, Levotas may also adversely react with other medicines. See below for a complete list.
In addition to the above precautions for Levotas, it is important to know that it is not safe while driving, and is not habit-forming.
Levotas is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Levotas is used -
Severe
Moderate
Mild
Is the use of Levotas safe for pregnant women?
Levotas may have some side effects during pregnancy. Pregnant women should discontinue the use of Levotas, and talk to their doctor, if they notice any discomfort.
Is the use of Levotas safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Levotas. So it is adviced to consult the doctor before using it.
What is the effect of Levotas on the Kidneys?
Levotas may have mild side effects on the kidneys.
What is the effect of Levotas on the Liver?
Levotas is not harmful for the liver.
What is the effect of Levotas on the Heart?
There are no any side effects of Levotas for the heart.
Levotas should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Levotas unless your doctor advises you to do so -
Is this Levotas habit forming or addictive?
No, there is no any evidence that Levotas is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Levotas you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but take Levotas only as per medical advice.
Is it able to treat mental disorders?
Levotas is unable to treat or cure mental disorders.
Interaction between Food and Levotas
Eating certain foods may increase the time it takes Levotas to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Levotas
Taking Levotas and alcohol together may cause some problems. If you notice any of these side effects, it is best to go to your doctor.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Levaquin® (levofloxacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1399
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Levaquin® (levofloxacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1399
